UPF26 / SCC Nexus

SCC Nexus · UPF26 evidence observatory

Business collaboration brief

Public, redacted exploration of practical opportunities. No confidential research assets, commercial forecasts or unsupported product claims.

Commercial status: exploration only. The methodology is a DRAFT and the formal scientific pilot has not started. UPF26 is not currently advertised here as a certified scoring tool, a clinically validated product, a regulatory decision engine or a source of proven commercial returns.
Opportunity A

Auditable evidence infrastructure

Potential collaborations around public-source tracking, source lineage, metadata qualification, archive integrity, version history and corrections.

Candidate deliverable: scoped evidence-dashboard demonstration using publicly shareable datasets.

Opportunity B

Reproducible methods

Potential research-tooling work using explicit classification rule versions, structured observations, blinded-review workflows and reproducible reports.

Candidate deliverable: methodology demonstrator, subject to scope, legal terms and scientific scrutiny.

Opportunity C

Evidence literacy and reporting

Explainers that distinguish processing classification, nutrient composition, exposure assumptions, observational association and causal claims.

Candidate deliverable: a transparently sourced workshop or public methods briefing, not individual dietary advice.

Controls

What remains confidential

Private evidence packs, partner and reviewer identities, unpublished interpretations, unreleased prospective predictions, access tokens, commercial terms and any personal data are not disclosed on these pages.

No external organisation or partner is implied to endorse this work.

Commercial due diligence, openly acknowledged

QuestionPublic position
Has the prospective empirical pilot validated the method?No; the pilot has not started.
Is there an independently audited commercial performance claim?No claim is made.
Can private case-level datasets be downloaded?No. Access requires explicit rights and separate review.
Is the public evidence monitoring operational?Automated snapshots and a public archive are available; ingestion success is not scientific validation.
How are commercial terms decided?By separate written agreement after scoping, rights and risk assessment.

All information on this page is intentionally public and redacted for external discussion. It is not an investment offer, regulated health claim or commitment to provide services.